Butobarbital

In this article, we will explore in depth Butobarbital and its impact on contemporary society. From its origin to its current evolution, Butobarbital has been the subject of interest and debate in various areas, both in popular culture and in academia. We will delve into its meaning, influence and relevance in today's world, analyzing how Butobarbital has shaped our perceptions, attitudes and behaviors. Through this analysis, we will seek to understand the implications of Butobarbital in our society and reflect on its role in human development.

Not to be confused with Butabarbital.
Butobarbital
Clinical data
Trade namesSoneryl
AHFS/Drugs.comInternational Drug Names
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Pharmacokinetic data
MetabolismLiver
ExcretionKidney
Identifiers
  • 5-Butyl-5-ethyl-1,3-diazinane-2,4,6-trione
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.928 Edit this at Wikidata
Chemical and physical data
FormulaC10H16N2O3
Molar mass212.249 g·mol−1
3D model (JSmol)
  • O=C1NC(=O)NC(=O)C1(CCCC)CC
  • InChI=1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15) checkY
  • Key:STDBAQMTJLUMFW-UHFFFAOYSA-N checkY
  (verify)

Butobarbital, also called butobarbitone or butethal, Soneryl, and Neonal, is a hypnotic drug which is a barbiturate derivative. It was developed by Poulenc Brothers (now part of Sanofi) in 1921.

References

  1. ^ International Drug Names
  2. ^ Nordegren T (2002). "Butobarbital". The A-Z encyclopedia of alcohol and drug abuse. Parkland, Fla.: Brown Walker Press. p. 144. ISBN 978-1-58112-404-0.
  3. ^ DE 481129, "Verfahren zur Herstellung von n-Butylaethylbarbitursaeure", published 3 February 1922, issued 14 August 1929, assigned to ETS Poulenc Freres. 


Stub icon

This sedative-related article is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia